Ayurvedic Interventions in prevention of COVID-19 infection-A survey study

Impact of Ayurvedic Interventions in prevention of COVID-19 infection in containment areas of Delhi- A community based study

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025069

Enrollment

9200

Registered

2020-05-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Shanshamani Vati or Sudarshana Ghanavati or Ashwagandha: 1.Sanshamani Vati 500mg Two times Before meal with water for 1 month 2.Sudarshna Ghanavati 500mg two times before meal with wate

Eligibility

Inclusion criteria

Inclusion criteria: 1 Aged 18 to 70 years of both male or female 2 Residents of the identified containment zones, marked by Govt. of NCT Delhi for high risk of COVID 19 3 Willing to take study medication; 4 Provides written informed consent prior to initiation of study procedures (or legally authorized representative). Only the copy of photography of informed consent would be kept for records.

Exclusion criteria

Exclusion criteria: 1 Persons already treated with any of the study drugs during the last 30 days; 2 Pregnant and lactating females and those who have a pregnancy plan 3 Participants with any immunosuppressive medication or in an immune compromised state or haematological disease. 4 Laboratory confirmed COVID-19 with or without symptoms. 5 Known allergy to any of the medications used in this trial. 6 Not willing to participate in the study. 7 Any other criteria, as per the investigator would jeopardize the study.

Design outcomes

Primary

Measure	Time frame
Incidence of COVID 19 positive cases (as confirmed by hospital by standard investigation (real-time polymerase chain reaction test) among Ayurveda usersTimepoint: 3) After enrolment on day one, assessment will be done on day 7, 15, 22 and 30 by telephonic communication or as convenient to the participant.	—

Secondary

Measure	Time frame
1) Incidence of severe COVID 19 positive cases among Ayurveda users 2) Incidence of mortality due to COVID 19 among Ayurveda users. 3) Incidence of any other ailment like cough, fever, sore throat etc during this study 4) Change in appetite, bowel habit, sleep among the users. 5) ADR/AE due to use of any particular Ayurveda advocaciesTimepoint: After enrolment on day one, assessment will be done on day 7, 15, 22 and 30 by telephonic communication or as convenient to the participant.	—

Measure

Time frame

1) Incidence of severe COVID 19 positive cases among Ayurveda users 2) Incidence of mortality due to COVID 19 among Ayurveda users. 3) Incidence of any other ailment like cough, fever, sore throat etc during this study 4) Change in appetite, bowel habit, sleep among the users. 5) ADR/AE due to use of any particular Ayurveda advocaciesTimepoint: After enrolment on day one, assessment will be done on day 7, 15, 22 and 30 by telephonic communication or as convenient to the participant.

—

Countries

India

Contacts

Public ContactDr Babita Yadav

Central Council for Research in Ayurvedic Sciences

drbabitayadav@gmail.com

Outcome results